Personal tools
You are here: Home Documents PubFiles Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma
Navigation
Log in


Forgot your password?
 
Document Actions

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

by Stefania Parodi last modified 2009-11-04 17:14

Santarpia L, Sherman SI, Marabotti A, Clayman GL, El-Naggar AK. Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma. Hum Pathol, Jun 2009;40(6):827-33

To assess the mutational status of BRAF in FVPTC, we directly sequenced the genomic DNA of 30 primary FVPTC samples. BRAF mutations were found in only 4 (13%) tumors. We also identified a previously unknown (novel) mutation in the activation kinase domain of the BRAF (A598V), replacing alanine with valine. Functional analysis showed that this mutation led to the up-regulation of the BRAF kinase activity and its downstream signaling factors. The effect of this mutation on the structural formation of the protein is highlighted. Our results confirm the infrequency of BRAF (V600E) mutation in FVPTC and identify a novel (A598V) mutation of this gene.

News subscription
To receive all RNBIO news in your email box
NEWS SUBSCRIPTION


Past news archive News Unsubscription


« May 2011 »
Su Mo Tu We Th Fr Sa
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: